This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
Chemotherapy-induced Peripheral Neuropathy, Quality of Life
This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.
International CIPN Assessment and Validation Study
-
Birmingham School of Nursing, University of Alabama, Birmingham, Alabama, United States, 35294
Northside Hospital, Atlanta, Georgia, United States, 30342
JHU, Baltimore, Maryland, United States, 21224
University of Michigan School of Nursing, Ann Arbor, Michigan, United States, 48109
Columbia University Irving Medical Center, New York, New York, United States, 10027
Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division, Columbus, Ohio, United States, 43220
Dartmouth-Hitchcock Medical Center, Lebanon, Pennsylvania, United States, 03756
University of Vermont Medical Center, Burlington, Vermont, United States, 05445
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of Milano Bicocca,
GUIDO CAVALETTI, MD, STUDY_CHAIR, University of Milano Bicocca
PAOLA ALBERTI, MD, PRINCIPAL_INVESTIGATOR, University of Milano Bicocca
2025-10-01